Lipocine Inc (LPCN) 13F Holdings Overview (Q2 2026)

LPCN ranks #7019 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

36 institutions disclose a position in LPCN, but none treat it as a major bet — even Squadron Capital Management LLC, its most concentrated holder, allocates just 0.6% of its own portfolio to it.

Jane Street Group, LLC has added to its LPCN position for two straight quarters, increasing it by $158.9K to reach $243.8K today.

Squadron Capital Management LLC has trimmed its LPCN position for two straight quarters, cutting it by $2.2M while still holding $2.1M.

LPCN is down 2.7% today, but institutions show net buying of $1.9M this quarter — a divergence between today's price move and the underlying institutional flow.

LPCN reported a net loss of $11.9M over the trailing twelve months.

• Not yet profitable — net loss of $11.9M over the trailing twelve months
• Revenue declined 62.7% year over year
• Net income declined year over year, from -$4.5M to -$11.9M
• Operating cash flow was negative, using $9.8M in cash
• Current ratio of 6.68x — enough short-term assets to cover short-term liabilities
• Liabilities run 282.67x equity — a highly leveraged balance sheet worth noting